Hepatocellular carcinoma (HCC) is the most common type of primary hepatocellular carcinoma (PHC). Early diagnosis of HCC remains the key to improve the prognosis. In recent years, with the promotion of the concept of precision medicine and more in-depth analysis of the biological mechanism underlying HCC, new diagnostic methods, including emerging serum markers, liquid biopsies, molecular diagnosis, and advances in imaging (novel contrast agents and radiomics), have emerged one after another. Herein, we reviewed and analyzed scientific advances in the early diagnosis of HCC and discussed their application and shortcomings. This review aimed to provide a reference for scientific research and clinical practice of HCC.
CITATION STYLE
Wang, Z., Qin, H., Liu, S., Sheng, J., & Zhang, X. (2023, May 20). Precision diagnosis of hepatocellular carcinoma. Chinese Medical Journal. Lippincott Williams and Wilkins. https://doi.org/10.1097/CM9.0000000000002641
Mendeley helps you to discover research relevant for your work.